Skip to main content

Table 2 Incidence of hypotension and minimum MAP (n = 60 in each group)

From: Efficacy and safety of remimazolam compared with propofol in hypertensive patients undergoing breast cancer surgery: a single-center, randomized, controlled study

 

Propofol group

Remimazolam group

Chi-square value or t-value

P-value

Incidence of hypotension n (%)

    

During the induction (total)

35 (58.3)

22 (36.7)

5.647

0.017*

During the induction (elderly)

23 (60.5)

17 (45.9)

1.601

0.206

During the induction (adult)

12 (54.5)

5 (21.7)

5.148

0.023*

During the maintenance

31 (51.7)

31 (51.7)

0.000

> 0.99

In the PACU

1 (1.7)

2 (3.4)

0.000

0.988

Minimum MAP (mmHg)

    

During the induction

66.7 ± 8.8

71.3 ± 7.7

-3.004

0.003*

During the maintenance

69.4 ± 6.4

70.9 ± 6.3

-1.253

0.210

In the PACU

92.5 ± 10.9

90.6 ± 10.1

0.989

0.330

  1. Notes: Data on the incidence of hypotension are presented as numbers (percentages). Data for the minimum MAP are presented as mean ± standard deviation. *P < 0.05, compared with the propofol group
  2. Abbreviations: MAP, mean arterial pressure; PACU, post-anesthesia care unit